So we can now predict with some precision the evolution of a group of MCI patients... That´s fantastic! This means that we can now easily say "this patient has a high likelihood to convert to vascular dementia, lets optimize his/her treatment including cardiovascular protective approaches".
This is really a step forward in the current manage of MCI patients. I´d like to be provided with such a test in my clinical practice. Is it going to be commercialized?
Practical parameter
10 February 2009
So we can now predict with some precision the evolution of a group of MCI patients... That´s fantastic! This means that we can now easily say "this patient has a high likelihood to convert to vascular dementia, lets optimize his/her treatment including cardiovascular protective approaches".
This is really a step forward in the current manage of MCI patients. I´d like to be provided with such a test in my clinical practice. Is it going to be commercialized?
Competing interests
None